• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Food Allergy - Pipeline Review, H2 2012 Product Image

Food Allergy - Pipeline Review, H2 2012

  • ID: 2366411
  • December 2012
  • 38 Pages
  • Global Markets Direct

FEATURED COMPANIES

  • Biomay AG
  • DBV Technologies
  • Novartis AG
  • Selecta Biosciences, Inc.
  • MORE

Food Allergy – Pipeline Review, H2 2012

Summary

Global Markets Direct's, 'Food Allergy - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Food Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Food Allergy. Food Allergy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Food Allergy.
- A review of the Food Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biomay AG
  • DBV Technologies
  • Novartis AG
  • Selecta Biosciences, Inc.
  • MORE

2
List of Tables 4
List of Figures 4
Introduction 5
REPORT COVERAGE 5
Food Allergy Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Food Allergy 7
Food Allergy Therapeutics under Development by Companies 9
Food Allergy Therapeutics under Investigation by Universities/Institutes 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Early Clinical Stage Products 12
Comparative Analysis 12
Discovery and Pre-Clinical Stage Products 13
Comparative Analysis 13
Food Allergy Therapeutics – Products under Development by Companies 14
Food Allergy Therapeutics – Products under Investigation by Universities/Institutes 15
Companies Involved in Food Allergy Therapeutics Development 16
Novartis AG 16
DBV Technologies 17
Selecta Biosciences, Inc. 18
Biomay AG 19
Food Allergy – Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Assessment by Route of Administration 21
Assessment by Molecule Type 23
Drug Profiles 25
omalizumab - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
omalizumab - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Trichuris Suis Ova - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Fish Allergen Hypoallergenic Vaccine - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
QGE-031 - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
GE-2 - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Allergen Vaccine Program - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
t2SVP For Food Allergy - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Food Allergy Therapeutics – Drug Profile Updates 35
Appendix 37
Methodology 37
Coverage 37
Secondary Research 37
Primary Research 37
Expert Panel Validation 37
Contact Us 38
Disclaimer 38

List of Tables
Number of Products Under Development for Food Allergy, H2 2012 7
Products under Development for Food Allergy – Comparative Analysis, H2 2012 8
Number of Products under Development by Companies, H2 2012 9
Number of Products under Investigation by Universities/Institutes, H2 2012 10
Comparative Analysis by Mid Clinical Stage Development, H2 2012 11
Comparative Analysis by Early Clinical Stage Development, H2 2012 12
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2012 13
Products under Development by Companies, H2 2012 14
Products under Investigation by Universities/Institutes, H2 2012 15
Novartis AG, H2 2012 16
DBV Technologies, H2 2012 17
Selecta Biosciences, Inc., H2 2012 18
Biomay AG, H2 2012 19
Assessment by Monotherapy Products, H2 2012 20
Assessment by Stage and Route of Administration, H2 2012 22
Assessment by Stage and Molecule Type, H2 2012 24
Food Allergy Therapeutics – Drug Profile Updates 35

List of Figures
Number of Products under Development for Food Allergy, H2 2012 7
Products under Development for Food Allergy – Comparative Analysis, H2 2012 8
Products under Development by Companies, H2 2012 9
Products under Investigation by Universities/Institutes, H2 2012 10
Mid Clinical Stage Products, H2 2012 11
Early Clinical Stage Products, H2 2012 12
Discovery and Pre-Clinical Stage Products, H2 2012 13
Assessment by Monotherapy Products, H2 2012 20
Assessment by Route of Administration, H2 2012 21
Assessment by Stage and Route of Administration, H2 2012 22
Assessment by Molecule Type, H2 2012 23
Assessment by Stage and Molecule Type, H2 2012 24

Note: Product cover images may vary from those shown

- Novartis AG
- DBV Technologies
- Selecta Biosciences, Inc.
- Biomay AG

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos